Glulisine Versus Regular Insulin for Hospitalized Patients with Type 2 Diabetes or Hospital-Related Hyperglycemia: A Randomized Double-Blind Trial

被引：0
|
作者：
Boron, Anna
Voltchenok, Marina
Vedda, Rosemarie
Plummer, Elena
Meyer, Christian
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A137 / A137
页数：1
相关论文
共 50 条
  • [21] Effect of JYTK on Antioxidant Status and Inflammation in Patients With Type 2 Diabetes: A Randomized Double-Blind Clinical Trial
    Hu, Yuan
    Zhou, Xin
    Guo, Dai-Hong
    Liu, Ping
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2016, 14 (01)
  • [22] Randomized Double-Blind Clinical Trial Comparaing Efficacy and Safety of Pioglitazone and Metformin in Patients with Type 2 Diabetes
    Rokeya, Begum
    Parvin, Masuma
    Bhowmik, Amrita
    Chowdhury, A. K. Azad
    DIABETES, 2011, 60 : A618 - A618
  • [23] Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial
    Kang, Ruiying
    He, Yan
    Yan, Yuxiang
    Li, Zhiwu
    Wu, Yeqing
    Guo, Xiaojuan
    Liang, Zhigang
    Jiang, Jun
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 1307 - 1311
  • [24] The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial
    Hodaei, Homa
    Adibian, Mahsa
    Nikpayam, Omid
    Hedayati, Mehdi
    Sohrab, Golbon
    DIABETOLOGY & METABOLIC SYNDROME, 2019, 11
  • [25] Efficacy and safety of empagliflozin as add-on to insulin in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial
    Sone, Hirohito
    Kaneko, Tatsuroh
    Shiki, Kosuke
    Tachibana, Yoshifumi
    Pfarr, Egon
    Lee, Jisoo
    Tajima, Naoko
    DIABETES OBESITY & METABOLISM, 2020, 22 (03): : 417 - 426
  • [26] The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial
    Homa Hodaei
    Mahsa Adibian
    Omid Nikpayam
    Mehdi Hedayati
    Golbon Sohrab
    Diabetology & Metabolic Syndrome, 11
  • [27] A Randomized Trial of Two Weight-Based Doses of Insulin Glargine and Glulisine in Hospitalized Subjects With Type 2 Diabetes and Renal Insufficiency
    Baldwin, David
    Zander, Jennifer
    Munoz, Christina
    Raghu, Preeya
    DeLange-Hudec, Susan
    Lee, Hong
    Emanuele, Mary Ann
    Glossop, Valerie
    Smallwood, Kimberly
    Molitch, Mark
    DIABETES CARE, 2012, 35 (10) : 1970 - 1974
  • [28] Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial
    S. Bo
    V. Ponzo
    A. Evangelista
    G. Ciccone
    I. Goitre
    F. Saba
    M. Procopio
    M. Cassader
    R. Gambino
    Acta Diabetologica, 2017, 54 : 499 - 507
  • [29] Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial
    Bo, S.
    Ponzo, V.
    Evangelista, A.
    Ciccone, G.
    Goitre, I.
    Saba, F.
    Procopio, M.
    Cassader, M.
    Gambino, R.
    ACTA DIABETOLOGICA, 2017, 54 (05) : 499 - 507
  • [30] Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial
    Tatovic, Danijela
    Marwaha, Ashish
    Taylor, Peter
    Hanna, Stephanie J.
    Carter, Kym
    Cheung, W. Y.
    Luzio, Steve
    Dunseath, Gareth
    Hutchings, Hayley A.
    Holland, Gail
    Hiles, Steve
    Fegan, Greg
    Williams, Evangelia
    Yang, Jennie H. M.
    Domingo-Vila, Clara
    Pollock, Emily
    Wadud, Muntaha
    Ward-Hartstonge, Kirsten
    Marques-Jones, Susie
    Bowen-Morris, Jane
    Stenson, Rachel
    Levings, Megan K.
    Gregory, John W.
    Tree, Timothy I. M.
    Dayan, Colin
    USTEKID Study Gp, Evelien
    NATURE MEDICINE, 2024, 30 (09) : 2657 - 2666
12345